NPI: 1346480837 · CHULA VISTA, CA 91910 · Federally Qualified Health Center (FQHC) · NPI assigned 02/24/2009
Authorized official ROMAN, RICARDO controls 20+ related entities in our dataset. Read more
| Authorized Official | ROMAN, RICARDO (CFO) |
| NPI Enumeration Date | 02/24/2009 |
Other providers sharing the same authorized official: ROMAN, RICARDO
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 48,741 | $6.45M |
| 2019 | 76,188 | $5.95M |
| 2020 | 143,244 | $8.67M |
| 2021 | 149,932 | $8.67M |
| 2022 | 109,153 | $6.88M |
| 2023 | 138,167 | $8.58M |
| 2024 | 36,283 | $2.65M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| T1015 | Clinic visit/encounter, all-inclusive | 287,158 | 197,025 | $47.53M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 6,605 | 3,348 | $73K |
| 98941 | Chiropractic manipulative treatment; spinal, 3-4 regions | 5,549 | 4,012 | $37K |
| G0467 | Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 1,285 | 1,132 | $34K |
| 0013A | 316 | 315 | $21K | |
| 0004A | 309 | 309 | $20K | |
| H1001 | Prenatal care, at-risk enhanced service; antepartum management | 292 | 250 | $18K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 1,730 | 962 | $15K |
| 0002A | 216 | 210 | $14K | |
| 90834 | Psychotherapy, 45 minutes with patient | 1,483 | 1,369 | $13K |
| 0001A | 172 | 166 | $11K | |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 51,143 | 45,288 | $9K |
| 98940 | 1,815 | 1,324 | $8K | |
| 0124A | 125 | 120 | $8K | |
| 0134A | 108 | 108 | $7K | |
| 97161 | 163 | 157 | $6K | |
| 0012A | 56 | 54 | $4K | |
| G9920 | Screening performed and negative | 547 | 546 | $4K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 35,398 | 32,639 | $3K |
| 0071A | 52 | 52 | $3K | |
| 96156 | 124 | 117 | $3K | |
| G2025 | Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only | 209 | 199 | $2K |
| 0011A | 48 | 43 | $2K | |
| 97162 | 538 | 527 | $1K | |
| 90791 | Psychiatric diagnostic evaluation | 251 | 251 | $1K |
| 98942 | 233 | 173 | $1K | |
| 80061 | Lipid panel | 8,515 | 8,506 | $1K |
| 0072A | 18 | 18 | $1K | |
| 90686 | 4,591 | 4,587 | $1K | |
| 98960 | 1,272 | 1,199 | $1K | |
| 80053 | Comprehensive metabolic panel | 9,121 | 9,067 | $885.87 |
| 0003A | 12 | 12 | $804.00 | |
| 90630 | 36 | 36 | $786.00 | |
| H1003 | Prenatal care, at-risk enhanced service; education | 44 | 37 | $639.58 |
| 83036 | Hemoglobin; glycosylated (A1C) | 7,605 | 7,597 | $595.98 |
| 97803 | 7,683 | 7,634 | $496.61 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 11,415 | 11,333 | $458.48 |
| 90688 | 270 | 269 | $440.00 | |
| 90756 | 1,577 | 1,576 | $249.00 | |
| 84443 | Thyroid stimulating hormone (TSH) | 7,030 | 7,011 | $241.53 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 13,043 | 12,194 | $218.85 |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1,019 | 1,019 | $179.70 |
| 99401 | 767 | 761 | $167.02 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 8,845 | 8,744 | $111.98 |
| 81002 | 9,520 | 6,760 | $96.53 | |
| 97164 | 294 | 284 | $94.14 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 4,609 | 4,571 | $13.26 |
| 86803 | 2,038 | 2,034 | $12.57 | |
| 86704 | 1,461 | 1,456 | $10.83 | |
| 96127 | 3,046 | 3,005 | $9.62 | |
| 86706 | 1,580 | 1,575 | $9.51 | |
| 87340 | 591 | 588 | $9.12 | |
| 90670 | 2,356 | 2,356 | $8.92 | |
| 90698 | 1,418 | 1,418 | $8.92 | |
| 84460 | 1,310 | 1,302 | $4.58 | |
| 90633 | 1,333 | 1,285 | $4.46 | |
| 84450 | 1,316 | 1,308 | $4.41 | |
| 99000 | 5,265 | 5,116 | $3.63 | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1,315 | 1,314 | $0.00 |
| 90472 | Immunization administration, each additional vaccine (list separately) | 1,880 | 1,874 | $0.00 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 253 | 249 | $0.00 |
| X3904 | 12,717 | 6,243 | $0.00 | |
| 92553 | 201 | 200 | $0.00 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2,919 | 2,864 | $0.00 |
| 90715 | 1,846 | 1,844 | $0.00 | |
| 81003 | 3,796 | 3,743 | $0.00 | |
| 83540 | 651 | 649 | $0.00 | |
| 82570 | 1,158 | 1,152 | $0.00 | |
| 90734 | 510 | 510 | $0.00 | |
| 99173 | 4,844 | 4,842 | $0.00 | |
| Z6400 | 3,028 | 2,447 | $0.00 | |
| Z6200 | 826 | 826 | $0.00 | |
| 86708 | 107 | 107 | $0.00 | |
| 87210 | 1,642 | 1,628 | $0.00 | |
| 11721 | 526 | 523 | $0.00 | |
| 2028F | 1,531 | 1,508 | $0.00 | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 2,690 | 2,650 | $0.00 |
| Z6304 | 973 | 960 | $0.00 | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 2,022 | 2,022 | $0.00 |
| 84439 | 190 | 188 | $0.00 | |
| 90461 | 2,896 | 2,892 | $0.00 | |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 445 | 444 | $0.00 |
| V2020 | Frames, purchases | 1,500 | 1,500 | $0.00 |
| 81025 | 4,495 | 4,319 | $0.00 | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 2,866 | 2,842 | $0.00 |
| 90648 | 139 | 139 | $0.00 | |
| 85007 | 487 | 482 | $0.00 | |
| 82947 | 1,008 | 1,003 | $0.00 | |
| 90681 | 122 | 122 | $0.00 | |
| 86480 | 2,029 | 2,026 | $0.00 | |
| 90746 | 273 | 273 | $0.00 | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 94 | 94 | $0.00 |
| 90707 | 580 | 580 | $0.00 | |
| Z6308 | 51 | 51 | $0.00 | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 939 | 931 | $0.00 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 3,597 | 3,584 | $0.00 |
| Z6500 | 16 | 16 | $0.00 | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 2,415 | 2,371 | $0.00 |
| 90700 | 576 | 576 | $0.00 | |
| 99201 | 571 | 571 | $0.00 | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 2,809 | 2,808 | $0.00 |
| 90832 | Psychotherapy, 30 minutes with patient | 420 | 414 | $0.00 |
| Z6300 | 811 | 811 | $0.00 | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 533 | 480 | $0.00 |
| 92015 | Determination of refractive state | 3,308 | 3,300 | $0.00 |
| 85610 | 853 | 811 | $0.00 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 4,692 | 4,621 | $0.00 |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 331 | 331 | $0.00 |
| 99404 | 1,348 | 1,340 | $0.00 | |
| 80354 | 43 | 43 | $0.00 | |
| 92133 | 57 | 56 | $0.00 | |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 989 | 988 | $0.00 |
| 92340 | Fitting of spectacles, except for aphakia; monofocal | 1,160 | 1,160 | $0.00 |
| 96160 | 1,777 | 1,775 | $0.00 | |
| 90750 | 949 | 948 | $0.00 | |
| 59025 | Fetal non-stress test | 248 | 156 | $0.00 |
| 90714 | 12 | 12 | $0.00 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 678 | 666 | $0.00 |
| 90710 | 167 | 167 | $0.00 | |
| 92341 | 278 | 278 | $0.00 | |
| T1013 | Sign language or oral interpretive services, per 15 minutes | 673 | 595 | $0.00 |
| 91312 | 59 | 59 | $0.00 | |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 14 | 14 | $0.00 |
| 90713 | 65 | 65 | $0.00 | |
| 82248 | 31 | 27 | $0.00 | |
| 82247 | 36 | 30 | $0.00 | |
| 83718 | 33 | 33 | $0.00 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 687 | 681 | $0.00 |
| Z6414 | 96 | 92 | $0.00 | |
| 82274 | 43 | 43 | $0.00 | |
| 3078F | 90 | 90 | $0.00 | |
| 91313 | 20 | 20 | $0.00 | |
| 82465 | 33 | 33 | $0.00 | |
| 2022F | 28 | 28 | $0.00 | |
| 84550 | 14 | 13 | $0.00 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 14 | 14 | $0.00 |
| Z6402 | 884 | 884 | $0.00 | |
| 87081 | 832 | 830 | $0.00 | |
| A9300 | Exercise equipment | 310 | 281 | $0.00 |
| 82951 | 1,141 | 1,139 | $0.00 | |
| 36415 | Collection of venous blood by venipuncture | 8,056 | 7,730 | $0.00 |
| 85651 | 1,092 | 1,087 | $0.00 | |
| 91301 | 28 | 28 | $0.00 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 3,277 | 3,272 | $0.00 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 3,547 | 3,535 | $0.00 |
| 86592 | 3,274 | 3,258 | $0.00 | |
| 90716 | 621 | 621 | $0.00 | |
| 58300 | 26 | 26 | $0.00 | |
| Z1034 | 10,538 | 7,492 | $0.00 | |
| 90744 | 1,051 | 1,050 | $0.00 | |
| Z6204 | 1,334 | 1,309 | $0.00 | |
| 92551 | 4,640 | 4,626 | $0.00 | |
| 81015 | 3,223 | 3,135 | $0.00 | |
| X3908 | 875 | 628 | $0.00 | |
| 85018 | 5,426 | 5,401 | $0.00 | |
| 90732 | 199 | 198 | $0.00 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 2,674 | 2,615 | $0.00 |
| 93000 | 723 | 718 | $0.00 | |
| 81001 | 580 | 541 | $0.00 | |
| X3906 | 699 | 574 | $0.00 | |
| 94760 | 1,234 | 1,116 | $0.00 | |
| Z6410 | 1,613 | 1,539 | $0.00 | |
| 92250 | 2,408 | 2,403 | $0.00 | |
| 82043 | 994 | 993 | $0.00 | |
| 90651 | 1,084 | 1,084 | $0.00 | |
| 97802 | 1,943 | 1,940 | $0.00 | |
| 99406 | 632 | 589 | $0.00 | |
| 83550 | 539 | 537 | $0.00 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 140 | 139 | $0.00 |
| 87070 | 1,912 | 1,887 | $0.00 | |
| Z1038 | 462 | 458 | $0.00 | |
| 82728 | 645 | 642 | $0.00 | |
| 87428 | 1,499 | 1,483 | $0.00 | |
| 99402 | 398 | 393 | $0.00 | |
| 86140 | 433 | 430 | $0.00 | |
| X3924 | 6,196 | 5,508 | $0.00 | |
| Z6406 | 561 | 533 | $0.00 | |
| 99381 | 750 | 746 | $0.00 | |
| Z1032 | 609 | 608 | $0.00 | |
| 86769 | 92 | 92 | $0.00 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 659 | 613 | $0.00 |
| 90697 | 552 | 551 | $0.00 | |
| 97010 | 35 | 27 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 1,975 | 1,971 | $0.00 |
| 90680 | 1,509 | 1,509 | $0.00 | |
| 87536 | 28 | 28 | $0.00 | |
| 90739 | 271 | 270 | $0.00 | |
| 90677 | 465 | 464 | $0.00 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 1,067 | 1,066 | $0.00 |
| 90619 | 244 | 244 | $0.00 | |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | 141 | 121 | $0.00 |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | 94 | 81 | $0.00 |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | 189 | 188 | $0.00 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 97 | 81 | $0.00 |
| H0001 | Alcohol and/or drug assessment | 81 | 45 | $0.00 |
| 2023F | 476 | 475 | $0.00 | |
| 36416 | 506 | 501 | $0.00 | |
| 80048 | Basic metabolic panel (calcium, ionized) | 137 | 132 | $0.00 |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 2,472 | 2,472 | $0.00 |
| 90674 | 1,083 | 1,083 | $0.00 | |
| 92002 | 65 | 65 | $0.00 | |
| 99385 | 152 | 152 | $0.00 | |
| 84153 | 13 | 13 | $0.00 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 60 | 60 | $0.00 |
| 99459 | 140 | 140 | $0.00 | |
| 93922 | 90 | 90 | $0.00 | |
| 90620 | 13 | 13 | $0.00 | |
| 87522 | Neg quan hep c or qual rna | 44 | 40 | $0.00 |
| 80050 | General health panel | 87 | 87 | $0.00 |
| 86580 | 42 | 39 | $0.00 | |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | 120 | 109 | $0.00 |
| 99386 | 13 | 13 | $0.00 | |
| X3910 | 83 | 64 | $0.00 | |
| X3902 | 16 | 16 | $0.00 | |
| 83690 | 30 | 30 | $0.00 | |
| X4304 | 77 | 27 | $0.00 | |
| 90694 | 81 | 81 | $0.00 | |
| G8433 | Screening for depression not completed, documented patient or medical reason | 15 | 15 | $0.00 |
| 91200 | 14 | 14 | $0.00 | |
| J3490 | Unclassified drugs | 12 | 12 | $0.00 |
| 3074F | 92 | 92 | $0.00 | |
| 90696 | 36 | 36 | $0.00 | |
| 3008F | 90 | 90 | $0.00 |